Diabetes:营养更容易影响小于胎龄婴儿的身体组成

2012-08-07 ZinFingerNase 生物谷

根据一项发表在2012年8月Diabetes期刊上的研究,配方奶喂养(formula-fed, FOF)的小于胎龄(small-for-gestational-age, SGA)婴儿要比母乳喂养(breastfed, BRF)的SGA婴儿拥有较高内分泌水平的高分子量脂联素(adiponectin)和胰岛素生长因子-I(insulin growth factor-I, IGF-I)。 来自比利时卢

根据一项发表在2012年8月Diabetes期刊上的研究,配方奶喂养(formula-fed, FOF)的小于胎龄(small-for-gestational-age, SGA)婴儿要比母乳喂养(breastfed, BRF)的SGA婴儿拥有较高内分泌水平的高分子量脂联素(adiponectin)和胰岛素生长因子-I(insulin growth factor-I, IGF-I)。

来自比利时卢汶大学的研究员Francis de Zegher博士和同事们开展一项研究:对72名适于胎龄(appropriate-for-gestational-age, AGA)出生的对照婴儿与46名母乳喂养的SGA婴儿和56名配方奶喂养的SGA婴儿进行比较。配方奶喂养的婴儿吃标准配方奶或富含蛋白的配方奶。在出生时和四月大时,研究人员测量他们的身体组成、高分子量脂联素以及IGF-I。

在头4个月时,研究人员发现不论是接受母乳喂养还是接受配方奶喂养,SGA婴儿的追赶生长主要限于瘦体质量(lean mass)。相对于母乳喂养的AGA婴儿,母乳喂养的SGA婴儿拥有正常的高分子量脂联素和IGF-I水平。相反,配方奶喂养的SGA婴儿拥有水平增加的高分子量脂联素和IGF-I(特别是接受富含蛋白的配方奶喂养之后)。

总之,新生儿营养似乎影响更容易影响SGA婴儿的身体组成。

本文编译自Nutrition type affects endocrinology in SGA infants

doi: 10.2337/db11-1797
PMC:
PMID:

Body Composition and Circulating High-Molecular-Weight Adiponectin and IGF-I in Infants Born Small for Gestational Age Breast- Versus Formula-Feeding

Francis de Zegher1, Giorgia Sebastiani2,3, Marta Diaz2,3, David Sánchez-Infantes2,3, Abel Lopez-Bermejo4,5 and Lourdes Ibáñez

Prenatal growth restraint, if followed by postnatal overweight, confers risk for adult disease including diabetes. The mechanisms whereby neonatal nutrition may modulate such risk are poorly understood. We studied the effects of nutrition (breast-feeding [BRF] vs. formula-feeding [FOF]) on weight partitioning and endocrine state (as judged by high-molecular-weight [HMW] adiponectin and IGF-I) of infants born small for gestational age (SGA). Body composition (by absorptiometry), HMW adiponectin, and IGF-I were assessed at birth and 4 months in BRF infants born appropriate for gestational age (AGA; n = 72) and SGA infants receiving BRF (n = 46) or FOF (n = 56), the latter being randomized to receive a standard (FOF1) or protein-rich formula (FOF2). Compared with AGA-BRF infants, the catchup growth of SGA infants was confined to lean mass, independently of nutrition. Compared with AGA-BRF infants, SGA-BRF infants had normal HMW adiponectin and IGF-I levels at 4 months, whereas SGA-FOF infants had elevated levels of HMW adiponectin (particularly SGA-FOF1) and IGF-I (particularly SGA-FOF2). In conclusion, neonatal nutrition seems to influence endocrinology more readily than body composition of SGA infants. Follow-up will disclose whether the endocrine abnormalities in SGA-FOF infants can serve as early markers of an unfavorable metabolic course and whether they may contribute to design early interventions that prevent subsequent disease, including diabetes.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1740301, encodeId=65f01e4030102, content=<a href='/topic/show?id=f9f383688d0' target=_blank style='color:#2F92EE;'>#胎龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83688, encryptionId=f9f383688d0, topicName=胎龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c34728820, createdName=ms8538335253054589, createdTime=Thu Dec 13 13:14:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759172, encodeId=5b0c1e591723c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 06 13:14:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924110, encodeId=4d1b192411071, content=<a href='/topic/show?id=6ab89321e1b' target=_blank style='color:#2F92EE;'>#身体组成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93217, encryptionId=6ab89321e1b, topicName=身体组成)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Fri Aug 24 17:14:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900981, encodeId=32ec1900981db, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Feb 04 00:14:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636540, encodeId=7c14163654009, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 31 10:14:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1740301, encodeId=65f01e4030102, content=<a href='/topic/show?id=f9f383688d0' target=_blank style='color:#2F92EE;'>#胎龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83688, encryptionId=f9f383688d0, topicName=胎龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c34728820, createdName=ms8538335253054589, createdTime=Thu Dec 13 13:14:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759172, encodeId=5b0c1e591723c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 06 13:14:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924110, encodeId=4d1b192411071, content=<a href='/topic/show?id=6ab89321e1b' target=_blank style='color:#2F92EE;'>#身体组成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93217, encryptionId=6ab89321e1b, topicName=身体组成)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Fri Aug 24 17:14:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900981, encodeId=32ec1900981db, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Feb 04 00:14:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636540, encodeId=7c14163654009, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 31 10:14:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1740301, encodeId=65f01e4030102, content=<a href='/topic/show?id=f9f383688d0' target=_blank style='color:#2F92EE;'>#胎龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83688, encryptionId=f9f383688d0, topicName=胎龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c34728820, createdName=ms8538335253054589, createdTime=Thu Dec 13 13:14:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759172, encodeId=5b0c1e591723c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 06 13:14:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924110, encodeId=4d1b192411071, content=<a href='/topic/show?id=6ab89321e1b' target=_blank style='color:#2F92EE;'>#身体组成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93217, encryptionId=6ab89321e1b, topicName=身体组成)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Fri Aug 24 17:14:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900981, encodeId=32ec1900981db, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Feb 04 00:14:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636540, encodeId=7c14163654009, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 31 10:14:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1740301, encodeId=65f01e4030102, content=<a href='/topic/show?id=f9f383688d0' target=_blank style='color:#2F92EE;'>#胎龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83688, encryptionId=f9f383688d0, topicName=胎龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c34728820, createdName=ms8538335253054589, createdTime=Thu Dec 13 13:14:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759172, encodeId=5b0c1e591723c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 06 13:14:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924110, encodeId=4d1b192411071, content=<a href='/topic/show?id=6ab89321e1b' target=_blank style='color:#2F92EE;'>#身体组成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93217, encryptionId=6ab89321e1b, topicName=身体组成)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Fri Aug 24 17:14:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900981, encodeId=32ec1900981db, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Feb 04 00:14:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636540, encodeId=7c14163654009, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 31 10:14:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1740301, encodeId=65f01e4030102, content=<a href='/topic/show?id=f9f383688d0' target=_blank style='color:#2F92EE;'>#胎龄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83688, encryptionId=f9f383688d0, topicName=胎龄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c34728820, createdName=ms8538335253054589, createdTime=Thu Dec 13 13:14:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759172, encodeId=5b0c1e591723c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 06 13:14:00 CST 2012, time=2012-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924110, encodeId=4d1b192411071, content=<a href='/topic/show?id=6ab89321e1b' target=_blank style='color:#2F92EE;'>#身体组成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93217, encryptionId=6ab89321e1b, topicName=身体组成)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Fri Aug 24 17:14:00 CST 2012, time=2012-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900981, encodeId=32ec1900981db, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Feb 04 00:14:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636540, encodeId=7c14163654009, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 31 10:14:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]

相关资讯

营养,恶性肿瘤治疗的后盾

复旦大学附属中山医院营养科 高键  随着治疗技术与治疗方法的不断进步,恶性肿瘤已经被认为是一种可治可控的慢性疾病,肿瘤患者的生存时间较以往有了明显的延长。目前,通过营养指导和营养治疗提高患者的生存质量,已经成为恶性肿瘤综合治疗的重要组成部分。   恶性肿瘤患者普遍存在营养不良   恶性肿瘤患者死亡的最常见原因是营养不良和恶液质,其容易出现营养不良原因有:① 肿瘤属于消耗性疾病,长期的高代谢

AIM:不同人群摄取营养物质 癌症预防结局不同

机体摄取适当的营养素对肿瘤的预防是有帮助的,但我们还不能完全明确不同群体摄取某些个别营养物质对肿瘤预防的确切作用。近来,Arch Intern Med杂志发表的一项研究表明:罹患心血管疾病的人服用B族维生素和Ω3不饱和脂肪酸并不能达到预防肿瘤的目的。 研究人员共招募了2,501名受试者包括514名女性和1,987名男性,男性受试者占受试者总数的79.4%,这些受试者年龄均在45至80岁之间。